Uses:
- Treatment of idiopathic pulmonary fibrosis (IPF). Idiopathic pulmonary fibrosis is a type of lung disorder in which tissues of the lungs become scarred and inflamed, resulting in breathing difficulties.
Therapeutic effects:
- Reduces the production and accumulation of extracellular matrix (ECM) proteins, which contribute to the fibrosis and stiffening of lung tissue.
- Helps to slow the progression of the disease and improve lung function.
Important information:
- Do not use if you have severe liver disorders or kidney disorders.
- Do not use if you are taking fluvoxamine (which treats depression and obsessive-compulsive disorder).
- Do not use if you are allergic to any of the ingredients of this medicine.
- Do not drink grapefruit juice while taking this medicine.
Dosage and administration:
- Take in a dose and duration prescribed by your doctor.
- Swallow the tablets whole with water.
- Take the tablet after a meal at the same time each day to reduce the side effects.
- Do not crush or chew the tablets.
Safety advice:
- Pregnancy: may cause harm to the unborn baby. Consult your doctor before taking this medicine.
- Breastfeeding: not recommended while taking Pulmofib 267mg tablet.
- Lungs: consult your doctor if you experience any upper respiratory tract infection while taking Pulmofib 267mg tablet.
- Liver: before starting the treatment, performing a liver function test is recommended.
- Alcohol: it is unknown if drinking alcohol while taking a Pulmofib 267mg tablet is safe. Please speak with your physician.
- Driving: may cause dizziness or sleepiness. It is unsafe to drive while you are under this treatment.
Side effects:
- Serious: severe allergic reactions (swelling of face, lips, or tongue, wheezing, feeling faint), liver problems (yellowing of skin or eyes, dark urine, bruising, or bleeding).
- Common: nausea, vomiting, loss of appetite, tiredness, diarrhea, indigestion, headache, dizziness, skin reactions after exposure to sunlight, infections, weight loss, difficulty sleeping, changes in taste, cough, stomach pain, constipation, feeling bloated, heartburn, itchy, dry skin, muscle pain, joint pain, chest pain, shortness of breath.
FAQ:
How does Pulmofib 267mg tablet work? Pulmofib 267mg tablet works by reducing inflammation and fibrosis in the lungs. It inhibits the production of certain molecules that cause scarring and stiffening of the lung tissue.
How long should I take Pulmofib 267mg tablet? Pulmofib 267mg tablet is a long-term medication that is taken indefinitely for treating IPF. The duration of treatment may vary depending on the individual patient's response to the medication and other factors.
Who should not take Pulmofib 267mg tablet? Pulmofib 267mg tablet is not recommended for pregnant or breastfeeding women and those with severe liver or kidney disease.
What dosage of Pulmofib 267mg tablet should I take? The dosage of Pulmofib 267mg tablet may vary based on factors such as the patient's age, weight, renal function, and other medications they may be taking. Dosage adjustments may be necessary based on side effects or changes in the patient's condition.
What should I do if I miss a dose of Pulmofib 267mg tablet? If you miss a dose of Pulmofib 267mg tablet, take it as soon as you remember. Skip the missed dose and continue with your regular dosing schedule.
What tests should I take before starting Pulmofib 267mg tablet? Your doctor will recommend you to take a liver function test before starting the cycles with Pulmofib 267mg tablet to monitor the functioning level.
Fact box:
- Molecule name: Pirfenidone
- Therapeutic class: Antifibrotic drugs
- Pharmacological class: Transforming growth factor inhibitor
- Indication: Idiopathic pulmonary fibrosis